Aripiprazole in Children and Adolescents With Bipolar I Disorder
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to test the safety and efficacy of two doses of aripiprazole in
child and adolescent patients with bipolar I disorder, manic or mixed episode with or without
psychotic features.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.